News

Deal Announcements

iTherx Pharma Lands $3 Million In VC Funding

Tuesday, November 8, 2011 5:51:00 AM PDT | VentureDeal Staff
   San Diego, California  --  iTherx Pharmaceuticals has secured $3.2 million in new venture capital investment, according to an SEC regulatory filing.

iTherx is a clinical stage stealth mode company that is developing new treatments for Hepatitis C.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

The Chief Scientific Officer is Flossie Wong-Stall, who was previously director of the AIDS Research Institute at the University Of California, San Diego.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1